ENDPOINTS

Senate confirms Marty Makary as 27th FDA commissioner

The Senate on Tuesday voted 56-44 to confirm Johns Hopkins researcher Marty Maka...

J&J touts new survival data for lung cancer combo

Johnson & Johnson released new data suggesting its lung cancer combination Rybre...

Wave strengthens case for accelerated approval, with mo...

Wave Life Sciences shared updated results from a Phase 2 trial of its exon-skipp...

ElevateBio trims workforce by 17%

One of the biotech industry's most well-funded cell and gene therapy companies h...

Humacyte to raise $50M; Acrivon to focus on prexasertib...

Plus, news about Tribune Therapeutics and Leap Therapeutics: Humacyte’s $50M...

Endpoints Slack interview: Duke's Chatterjee on AI bio,...

The Endpoints News Slack chat is back for 2025, and we're starting with a 32-yea...

Epicrispr raises $68M, will start clinical trial of epi...

Decades ago, Amber Salzman remembers feeling like there was nothing she could do...

Trump tariffs would increase biopharma costs — industry...

The Trump administration's threatened tariffs on Europe would be painful for the...

Senate confirms Marty Makary as 26th FDA commissioner

The Senate on Tuesday voted 56-44 to confirm Johns Hopkins researcher Marty Maka...

Bhattacharya is confirmed by Senate as NIH chief

Stanford researcher Jay Bhattacharya has been confirmed as the new head of the N...

Lyndra Therapeutics to shut down after funding challenges

A company that sought to make long-acting forms of commonly used drugs, with bac...

Eisai cuts Leqembi 2027 sales projections by half

Eisai has slashed 2027 sales projections for its Biogen-partnered Alzheimer’s tr...

Senate committee backs Dr. Oz for CMS nomination 

Mehmet Oz’s nomination to lead CMS will advance to the full Senate after clearin...

Revvity wins $37.8M contract to screen UK newborns for ...

Diagnostics company Revvity will sequence the DNA of newborns to help identify r...

DOGE reverses three FDA lease closures on its 'Wall of ...

Elon Musk's Department of Government Efficiency has reversed its termination of ...

Illumina adds activist investor to board, taps ex-FDA h...

Illumina on Tuesday added activist investor Keith Meister to its board and named...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.